Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BullFrog AI Holdings, Inc. ( (BFRG) ) has issued an update.
On June 12, 2025, BullFrog AI Holdings, Inc. announced a strategic collaboration with Sygnature Discovery, a UK-based contract research organization specializing in drug discovery. This partnership will introduce BullFrog’s AI-driven data insights platform, BullFrog Data Networks™, to Sygnature’s global biopharma client base. The collaboration is a significant milestone for BullFrog AI, expected to enhance brand recognition and generate $15-$30 million in revenue through 2028. The initiative aims to accelerate innovation in drug discovery by providing advanced AI tools to small and mid-sized biopharma companies, thereby improving R&D efficiency and success rates.
More about BullFrog AI Holdings, Inc.
BullFrog AI Holdings, Inc. is a technology-enabled drug development company that leverages artificial intelligence and machine learning to facilitate the successful development of pharmaceuticals and biologics. The company focuses on using its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.
Average Trading Volume: 388,215
Technical Sentiment Signal: Sell
Current Market Cap: $17.89M
For detailed information about BFRG stock, go to TipRanks’ Stock Analysis page.